For: | Xi Y, Xu PF. Therapeutic potentials of fasudil in liver fibrosis. World J Gastroenterol 2021; 27(45): 7859-7861 [PMID: 34963748 DOI: 10.3748/wjg.v27.i45.7859] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i45/7859.htm |
Number | Citing Articles |
1 |
Yara A. Zaky, Mai W. Rashad, Marwa A. Zaater, Ahmed M. El Kerdawy. Discovery of dual rho-associated protein kinase 1 (ROCK1)/apoptosis signal–regulating kinase 1 (ASK1) inhibitors as a novel approach for non-alcoholic steatohepatitis (NASH) treatment. BMC Chemistry 2024; 18(1) doi: 10.1186/s13065-023-01081-3
|
2 |
Esam M. Aboubakr, Ahmed R. N. Ibrahim, Fares E. M. Ali, Ahmed A. E. Mourad, Adel M. Ahmad, Amal Hofni. Fasudil Ameliorates Methotrexate-Induced Hepatotoxicity by Modulation of Redox-Sensitive Signals. Pharmaceuticals 2022; 15(11): 1436 doi: 10.3390/ph15111436
|
3 |
Qiuyan Ye, Xue Li, Wei Gao, Jiayue Gao, Liping Zheng, Miaomiao Zhang, Fengge Yang, Honglin Li. Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases. Frontiers in Neuroscience 2024; 18 doi: 10.3389/fnins.2024.1481983
|
4 |
Siyu Zhao, Xin Chen, Rui Tan, Xiaoqing Wu, Hezhong Jiang. Research Progress in Natural Products against Liver Fibrosis. The Natural Products Journal 2025; 15(4) doi: 10.2174/0122103155293866240522085229
|
5 |
Hendrik Vercammen, Martin Ondra, Jana Kotulova, Edgar Cardenas De La Hoz, Charissa Witters, Katerina Jecmenova, Maxim Le Compte, Christophe Deben, Sorcha Ní Dhubhghaill, Carina Koppen, Marián Hajdúch, Bert Van den Bogerd. “Keep on ROCKIn”: Repurposed ROCK inhibitors to boost corneal endothelial regeneration. Biomedicine & Pharmacotherapy 2024; 174: 116435 doi: 10.1016/j.biopha.2024.116435
|